US Patent Issued to Charles Schaper on Nov. 18 for "Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products" (Connecticut Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,247, issued on Nov. 18, was assigned to Charles Schaper (Vernon, Conn.).

"Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products" was invented by Charles Schaper (Vernon, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are reactive aromatic molecules (e.g., substituted chrysene heterodimers) encodable as base-four sequences for the design and integrated synthesis of nucleic acids (e.g., DNA, RNA, hybrid DNA/RNA) and associated phospholipid bilayers (e.g., cellular membranes). For example, 3,6,9,12-tetrasubstituted chrysene is coupled with 6,12-disubstituted chrysene through P...